Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-05175157 in moderate to severe acne vulgaris
NCT02100527Phase 2Withdrawn
- Sponsor
- Pfizer
- Start
- Apr 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of PF-05175157 in acne vulgaris, sponsored by Pfizer. Planned start Apr 2014; status: withdrawn.
02
Drugs
PF-05175157
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02100527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02100527.